secwatch.observer — SEC 8-K summary
======================================

Issuer:     Summit Therapeutics Inc. (SMMT)
CIK:        0001599298
Form:       8-K
Filed at:   2024-01-03T23:59:59+00:00
Accession:  0001599298-24-000004
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Summit Therapeutics to present at J.P. Morgan Healthcare Conference on Jan 9, 2024
--------------------------------------------------------------------------------

- Presentation on January 9, 2024 at 1:30 PM PT; includes update on ivonescimab development.
- Robert W. Duggan (Chairman/CEO) and Dr. Maky Zanganeh (CEO/President) to present.
- Audio webcast available live and archived on company website (www.smmttx.com).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599298/000159929824000004/0001599298-24-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599298/000159929824000004/smmt-20240103.htm
  HTML page:      https://secwatch.observer/filing/0001599298-24-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer